Bring your portfolio to life with these stellar ASX healthcare shares

I think CSL Limited (ASX:CSL) and these ASX healthcare shares could generate strong returns for investors over the next 10 years. Here's why..

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for buy and hold investment options, then I think the healthcare sector is a great place to start.

This is because in this sector there are a number of companies with the potential to grow materially over the next decade.

With that in mind, here are three top ASX healthcare shares I would buy right now:

CSL Limited (ASX: CSL)

I think the leading biotherapeutics company is a healthcare share to buy. This is because of its high quality businesses and their portfolio of life-saving therapies and vaccines. The good news is that management never rests on its laurels. Each year it invests hundreds of millions of dollars into its research and development. This means CSL has a large number of therapies in its pipeline that have the potential to save lives and generate significant sales over the next decade. Overall, I believe this should underpin strong earnings growth in the coming years and send the CSL share price higher.

Nanosonics Ltd (ASX: NAN)

Another ASX healthcare share to consider buying is this infection prevention company. I'm a big fan of Nanosonics due to its industry-leading trophon EPR disinfection system for ultrasound probes. I think this product alone could drive strong earnings growth over the next decade thanks to its sizeable market opportunity and growing recurring revenues. However, with the company aiming to release a number of new products targeting other unmet needs in the coming years, Nanosonics' growth could go up a level in the near future. In light of this, I think now would be a good time to buy and hold Nanosonics shares.

Pro Medicus Limited (ASX: PME)

A final healthcare share to consider buying is Pro Medicus. It is a healthcare technology company which provides radiology IT software and services to hospitals, imaging centres, and healthcare groups. Its popular Visage 7 Enterprise Imaging Platform delivers fast, multi-dimensional images which are streamed via an intelligent thin-client viewer. A number of major healthcare institutions are using Visage 7, including the Northwestern Memorial HealthCare. Last month Pro Medicus signed major new contract worth $22 million with the Chicago-based healthcare company. It also revealed that it has a number of sales opportunities in its pipeline that it is working on. I believe this bodes well for its future growth and could be the key to driving the Pro Medicus share price notably higher over the coming years.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Nanosonics Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »